From Name

From Email

To Name

To Email

Message

How COVID-19 has affected launches of new oncology therapies in the US

from PharmExec.com

How COVID-19 has affected launches of new oncology therapies in the US PharmExec.com How has the pandemic impacted FDA approval timing relative to expectations? In short, it hasn’t, at least yet. The table below summarizes 2020 FDA approvals of new oncology therapies; no approvals have been delayed relative to expected PDUFA dates. In fact, the majority of approvals have been granted prior to expected PDUFA dates, in some cases coming even three to four months prior. READ MORE

more